首页> 外国专利> BETA-CARBOLINES AS POSITIVE ALLOSTERIC MODULATORS OF THE HUMAN SEROTONIN RECEPTOR 2C (5-HT2C)

BETA-CARBOLINES AS POSITIVE ALLOSTERIC MODULATORS OF THE HUMAN SEROTONIN RECEPTOR 2C (5-HT2C)

机译:β-碳水化合物作为人类5-羟色胺受体2C(5-HT 2C )的正变构调节剂

摘要

Disclosed are novel small molecules, methods of synthesis of the small molecules, and uses of the small molecules for modulating activity of the human serotonin receptor 2C (5-HT2c), preferably selectively. The small molecules have a substituted beta-carboline core structure, which optionally may be saturated at one or more bonds to provide a dihydro-beta-carboline core or a tetrahydro-beta-carboline core. The small molecules may be administered to treat and/or prevent diseases, disorders, and/or conditions associated with human serotonin receptor 2C (5- HT2C) including psychiatric, mental, and/or neurological diseases, disorders, and conditions such as cognitive impairment, addiction, and obsessive compulsive disorder. The disclosed small molecules also may be administered to treat and/or prevent obesity, for example, via appetite suppression.
机译:公开了新颖的小分子,该小分子的合成方法以及该小分子在调节人5-羟色胺受体2C(5-HT 2c )的活性中的用途,优选地选择性地。小分子具有取代的β-咔啉核心结构,其可任选地在一个或多个键处饱和以提供二氢-β-咔啉核心或四氢-β-咔啉核心。可以施用小分子来治疗和/或预防与人类血清素受体2C(5- HT 2C )相关的疾病,病症和/或状况,包括精神疾病,精神疾病和/或神经疾病,障碍和条件,例如认知障碍,成瘾和强迫症。还可以例如通过抑制食欲来施用所公开的小分子以治疗和/或预防肥胖。

著录项

  • 公开/公告号WO2020072675A1

    专利类型

  • 公开/公告日2020-04-09

    原文格式PDF

  • 申请/专利权人 NORTHWESTERN UNIVERSITY;

    申请/专利号WO2019US54337

  • 申请日2019-10-02

  • 分类号C07D471/04;A61K31/437;A61P25/18;A61P25/28;A61P25/30;

  • 国家 WO

  • 入库时间 2022-08-21 11:12:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号